Metagenomi, Inc.
MGX
$1.67
$0.159.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -16.50% | -42.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.50% | -42.45% | |||
| Cost of Revenue | -11.78% | -7.29% | |||
| Gross Profit | 8.09% | -77.36% | |||
| SG&A Expenses | -7.43% | -10.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.80% | -8.07% | |||
| Operating Income | 7.86% | -32.73% | |||
| Income Before Tax | -17.85% | -61.38% | |||
| Income Tax Expenses | 42.64% | 4.23% | |||
| Earnings from Continuing Operations | -24.64% | -74.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.64% | -74.81% | |||
| EBIT | 7.86% | -32.73% | |||
| EBITDA | 8.83% | -35.14% | |||
| EPS Basic | -22.84% | -74.15% | |||
| Normalized Basic EPS | 8.50% | -44.93% | |||
| EPS Diluted | -22.84% | -74.15% | |||
| Normalized Diluted EPS | 8.50% | -44.93% | |||
| Average Basic Shares Outstanding | 1.47% | 0.38% | |||
| Average Diluted Shares Outstanding | 1.47% | 0.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||